In recent years, there has been a tendency toward creating innovative, easy to use and patient-friendly drug delivery systems suitable for every consumer profile, which would ensure safety, stability and acceptability of a drug. One of the relatively novel and promising approaches is the manufacture of orodispersible films (ODFs), which is an upcoming area of interest in drug delivery. They are defined as polymer thin films that disintegrate in the oral cavity within seconds, without drinking water or chewing, and eliminate the risk of choking. Gaining special usefulness in therapies of children and the elderly, ODFs seem to fill the gap in the range of preparations available for these groups of patients. As no detailed monography of ODFs including testing methods and uniform requirements has been presented in any of the pharmacopoeias to date, the aim of this article is to give an overview of the applied testing methods, their modifications and innovative approaches related to ODF quality assessment.
6. M. Nishimura, M. Matsuura, T. Tsukioka, H. Yamashit, N. Inagaki, T. Sugiyama and Y. Itoh, In vitro and in vivo characteristics of prochlorperazine oral disintegrating film, Int. J. Pharm. 368 (2009) 98–102; https://doi.org/10.1016/j.ijpharm.2008.10.002
7. D. A. Satyanarayana and K. P. Keshavarao, Fast disintegrating films containing anatrozole as a dosage form for dysphagia patients, Arch. Pharmacal. Res. 35 (2012) 2171–2182; https://doi.org/10.1007/s12272-012-1215-3
8. M. Scarpa, S. Stegemann, W. K. Hsiao, H. Pichler, S. Gaisford, M. Bresciani, A. Paudel and M. Orlu, Orodispersible films: towards drug delivery in special populations, Int. J. Pharm. 523 (2017) 327–335; https://doi.org/10.1016/j.ijpharm.2017.03.018
9. R. Krampe, D. Sieber, M. Pein-Hackelbusch and J. Breitkreutz, A new biorelevant dissolution method for orodispersible films, Eur. J. Pharm. Biopharm. 98 (2016) 20–25; https://doi.org/10.1016/j.ejpb.2015.10.012
10. A. F. Borges, C. Silva, J. F. Coelho and S. Simões, Oral films: Current status and future perspectives I – Galenical development and quality attributes, J. Control. Release206 (2015) 1–19; https://doi.org/10.1016/j.jconrel.2015.03.006
12. J. C. Visser, H. J. Woerdenbag, L. M. Hanff and H. W.Frijlink, Personalized medicine in pediatrics: the clinical potential of orodispersible films, AAPS PharmSciTech18 (2017) 267–272; https://doi.org/10.1208/s12249-016-0515-1
13. J. C. Visser, H. J. Woerdenbag, S.Crediet, E. Gerrits, M. A. Lesschen, W. L. J. Hinrichs, J. Breitkreutz and H. W. Frijlink, Orodispersible films in individualized pharmacotherapy: the development of a formulation for pharmacy preparations, Int. J. Pharm. 478 (2015) 155–163; https://doi.org/10.1016/j.ijpharm.2014.11.013
29. V. Reiner, N. Giarratana, N. C. Monti, A. Breitenbach and P. Klaffenbach, Rapidfilm: an innovative pharmaceutical form designed to improve patient compliance, Int. J. Pharm. 393 (2010) 55–60; https://doi.org/10.1016/j.ijpharm.2010.03.055
37. L. Loprete, C. Leuratii, V. Frangione and M. Radicioni, Pharmacokinetics of a novel sildenafil orodispersible film administered by the supralingual and the sublingual route to healthy men, Clin. Drug Investig. 38 (2018) 765–772; https://doi.org/10.1007/s40261-018-0665-x
38. M. D. Siddiqui, G. Garg and P. Sharma, A short review on a novel approach in oral fast dissolving drug delivery system and their patents, Adv. Biol. Res. 5 (2011) 291–303.
39. B. Bhyan, H. Jangra, M. Kaurand are H. Singh, Orally fast dissolving films: innovations in formulation and technology, Int. J. Pharm. Sci. Rev. Res. 9 (2011) 50–56.
41. M. Hariharan and A. Bogue, Orally dissolving film strips (ODFS): the final evolution of orally dissolving dosage forms, Drug Deliv. Technol. 9 (2009) 24–29.
42. A. Alayoubi, L. Hayens, B. Daihom, R. Helms and H. Almoazen, Development of a fast dissolving film of epinephrine hydrochloride as a potential anaphylactic treatment for pediatrics, Pharm. Dev. Technol. 22 (2017) 1012–1016; https://doi.org/10.3109/10837450.2015.1131715
43. J. Aggarwal, G. Singh, S. Saini and A. C. Rana, Fast dissolving films: a novel approach to oral drug delivery, IRJP2 (2011) 69–74.
47. A. V. Yadav, A. S. Shete, A. P. Dabke, P. V. Kulkarni and S. S. Sakhare, Co-crystals: a novel approach to modify physicochemical properties of active pharmaceutical ingredients, Indian J. Pharm. Sci. 71 (2009) 359–370; https://doi.org/10.4103/0250-474X.57283
48. M. R. Gigliobianco, C. Casadidio, R. Censi and P. Di Martino, Nanocrystals of poorly soluble drugs: drug bioavailability and physicochemical stability, Pharmaceutics10 (2018) E134.;https://doi.org/10.3390/pharmaceutics10030134
49. S. Rao, Y. Song, F. Peddie and A. M. Evans, Particle size reduction to the nanometer range: a promising approach to improve buccal absorption of poorly water-soluble drugs, Int. J. Nanomedicine6 (2011) 1245–1251; hhtps://doi.org/10.2147/IJN.S19151
51. P. R. Vuddanda, M. Montenegro-Nicolini J. O. Morales and S. Velaga, Effect of surfactants and drug load on physico-mechanical and dissolution properties of nanocrystalline tadalafil-loaded oral films, Eur. J. Pharm. Biopharm. 85 (2013) 1348–1356; https://doi.org./10.1016/j.ejps.2017.08.019
52. B. D. Kevadiya, M. Barvaliya, L. Zhang, A. Anovadiya, H. Brahmbhatt, P. Paul and C. Tripathi, Fenofibrate nanocrystals embedded in oral strip-films for bioavailability enhancement, Bioengineering (Basel). 13 (2018) E16; https://doi.org/10.3390/bioengineering5010016
53. D. Steiner, J. H. Finke and A. Kwade, Efficient production of nanoparticle-loaded orodispersible films by process integration in a stirred media mill, Int. J. Pharm. 511 (2016) 804–813; https://doi.org/10.1016/j.ijpharm.2016.07.058
54. V. Garsuch and J. Breitkreutz, Comparative investigations on different polymers for the preparation of fast-dissolving oral films, J. Pharm. Pharmacol. 62 (2010) 539–545; https://doi.org/10.1211/jpp.62.04.0018
55. M. Irfan, S. Rabel, Q. Bukhtar, M. I. Quadir, F. Jabeen and A. Khan, Orally disintegrating films: a modern expansion in drug delivery systems, Saudi Pharm. J. 24 (2016) 537–546; https://doi.org/10.1016/j.jsps.2015.02.024
56. M. J. Chen, G. Tirol, C. Bass, C. M. Corniello, G. Watson and I. Sanchezet, Castable edible pharmaceutical films, Drug. Delivery Technol. 8 (2008) 34–41.
58. F. Cilurzo, I. E. Cupone, P. Minghetti, S. Buratti, F. Selmin, C. G. M. Gennari and L. Montanari, Nicotine fast dissolving films made of maltodextrins: a feasibility study, AAPS PharmSciTech11 (2010) 1511–1517; https://doi.org/10.1208/s12249-010-9525-6
59. J. S. Boateng, K. H. Matthews, A. D. Auffret, M. J. Humphrey, H. N. Stevens and G. M. Eccleston, In vitro drug release studies of polymeric freeze-dried wafers and solvent-cast films using paracetamol as a model soluble drug, Int. J. Pharm. 378 (2009) 66–72; https://doi.org/10.1016/j.ijpharm.2009.05.038
60. J. S. Boateng, H. N. Stevens, G. M. Eccleston, A. D. Auffret, M. J. Humphrey and K. H. Matthews, Development and mechanical characterization of solvent-cast polymeric films as potential drug delivery systems to mucosal surfaces, Drug Dev. Ind. Pharm. 35 (2009) 986–996; https://doi.org/10.1080/03639040902744704
61. Y. S. Pathare, V. S. Hastak and A. N. Bajaj, Polymers used for fast disintegrating oral films: a review, Int. J. Pharm. Sci. Rev. Res. 21 (2013) 169–178.
62. P. R. Vuddanda, M. Montenegro-Nicolini, J. O. Morales and S. Velaga, Effect of plasticizers on the physico-mechanical properties of pullulan based pharmaceutical oral films, Eur. J. Pharm. Sci. 96 (2017) 290–298; https://doi.org/10.1016/j.ejps.2016.09.011
63. C. Giovino, I. Ayensu, J. Tetteh and J. S. Boateng, An integrated buccal delivery system combining chitosan films impregnated with peptide loaded PEG-b-PLA nanoparticles, Colloids Surf. B. Biointerfaces112 (2013) 9–15; https://doi.org/10.1016/j.colsurfb.2013.07.019
64. Y. Murata, T. Isobe, K. Kofuji, N. Nishida and R. Kamaguchi, Preparation of fast dissolving films for oral dosage from natural polysaccharides, Materials3 (2010) 4291–4299; https://doi.org/10.3390/ma3084291
65. P. Nagar, I. Chauhan and M. Yasir, Insights into polymers: film formers in mouth dissolving films, Drug Invent. Today3 (2011) 280–289.
66. I. Ito, A. Ito and S. Unezaki, Preparation of an oral acetaminophen film that is expected to improve medication administration: effect of polyvinylpyrrolidone on physical properties of the film, Drug Discov. Ther. 10 (2016) 156–162; https://doi.org/10.5582/ddt.2016.01034
74. P. L. Travers, Mary Poppins, New York, Howe, 1934.
75. C. K. Brown, H. D. Friedel, A. R. Barker, L. F. Buhse, S. Keitel, T. L. Cecil, J. Kraemer, J. M. Morris, C. Reppas, M. P. Stickelmeyer, C. Yomota and P. V. Shah, FIP/AAPS joint workshop report: dissolution/in vitro release testing of novel/special dosage forms, AAPS PharmSciTec12 (2011) 782–794; https://doi.org/10.1208/s12249-011-9634-x
82. M. Siewert, J. Dressman, C. Brown and V. P. Shah, FIP/AAPS guidelines for dissolution/in vitro release testing of novel/special dosage forms, AAPS PharmSciTech. 4 (2003) 43–52; https://doi.org/10.1208/pt040107
83. European Pharmacopoeia 8, Strasbourg 2014.
84. United States Pharmacopoeia 37, National Formulary 32, US Pharmacopeial Convention, Rockville 2014.
85. J. Al-Gousous and P. Langguth, Oral solid dosage form disintegration testing – the forgotten test, J. Pharm. Sci. 104 (2015) 2664–2675; https://doi.org/10.1002/jps.24303
88. J. C. Visser, W. M. Dohmen, W. L. Hinrichs, J. Breitkreutz, H. W. Frijlinkand and H. J. Woerdenbag, Quality by design approach for optimizing the formulation and physical properties of extemporaneously prepared orodispersible films, Int. J. Pharm. 485 (2015) 70–76; https://doi.org/10.1016/j.ijpharm.2015.03.005
89. H. Okamoto, H. Taguchi, K. Iida and K. Danjo, Development of polymer film dosage forms of lidocaine for buccal administration, I. Penetration rate and release rate, J. Control. Release77 (2001) 253–260.
90. K. Müller, C. Fingueroa, C. Martinez, M. Madel, E. Obreque, A. Peña-Neira, I. Morales-Bozo, H. Toledo and R. O. Lopez-Solis, Measurement of saliva volume in the mouth of members of a trained sensory panel using a beetroot (Beta vulgaris) extract, Food Quality and Preference21 (2010) 569–574; https://doi.org/10.1016/j.foodqual.2010.03.005
91. M. Gohel, M. Patel, A. Amin, R. Agrawal, R. H. Dave and N. Bariya, Formulation design and optimization of mouth dissolve tablets of nimesulide using vacuum drying technique, AAPS Pharm-SciTech. 5 (2004) e36; https://doi.org/10.1208/pt050336
92. P. C. Patil, S. K. Shirvastava, S. Vaidehi and P. Ashwini, Oral fast dissolving drug delivery system: a modern approach for patient compliance, Int. J. Drug Regulat. Affairs2 (2014) 49–60.
94. I. Speer, D. Steiner, Y. Thabet, J. Breitkreutz and A. Kwade, Comparative study on disintegration methods for oral film preparations, Eur. J. Pharm. Biopharm. 132 (2018) 50–61; https://doi.org/10.1016/j.ejpb.2018.09.005
95. M. Preis, D. Gronkowsky, D. Grytzan and J. Breitkreutz, Comparative study on novel test systems to determine disintegration time of orodispersible films, J. Pharm. Pharmacol. 66 (2014) 1102–1111; https://doi.org/10.1111/jphp.12246
96. A. Low, S. L. Kok, Y. M. Khong, S. Y. Chan and R. Gokhale, A new test unit for disintegration endpoint determination of orodispersible films, J. Pharm. Sci. 104 (2015) 3893–3903; https://doi.org/10.1002/jps.24609
97. G. Szakonyi and R. Zelkó, Prediction of oral disintegration time of fast disintegrating tablets using texture analyzer and computational optimization, Int. J. Pharm. 448 (2013) 346–353; https://doi.org/10.1016/j.ijpharm.2013.03.047
98. R. H. Dave, D. A. Shah and P. G. Patel, Development and evaluation of high loading oral dissolving film of aspirin and acetaminophen, J. Pharm. Sci. Pharmacol. 1 (2014) 112–122; https://doi.org/10.1166/jpsp.2014.1014
100. J. I. Kim, S. M. Cho, J. H. Cui, Q. R. Cao, E. Oh and B. J. Lee, In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex, Int. J. Pharm. 455 (2013) 31–39; https://doi.org/10.1016/j.ijpharm.2013.07.072
101. S. Gittings, N. Turnbull, B. Henry, C. J. Roberts and P. Gershkovich, Characterisation of human saliva as a platform for oral dissolution medium development, Eur. J. Pharm. Biopharm. 91 (2015) 16–24; https://doi.org/.1016/j.ejpb.2015.01.007
102. M. Tiwari, Science behind human saliva, J. Nat. Sci. Biol. Med. 2 (2011) 53–58.
103. G. R. Batista, C. Rocha Gomes Torres, B. Sener, T. Attin and A. Wiegand, Artificial saliva formulations versus human saliva pretreatment in dental erosion experiments, Caries Res. 50 (2016) 78–86; https://doi.org/10.4103/0976-9668.82322
106. S. Saini, A. Nanda, M. Hooda and K. Chaudhary, Fast dissolving films (FDF): innovative drug delivery system, Pharmacologyonline2 (2011) 919–928.
107.M. R. C. Marques, R. Loebenberg and M. Almukainzi, Simulated biological fluids with possible application in dissolution testing, Dissolut. Technol. 18 (2011) 15–28; https://doi.org/10.14227/DT180311P15.
109. M. Guhmann, M. Preis, F. Gerber, N. Pollinger and J. Breitkreutz, W. Weitschies, Development of oral taste masked diclofenac formulations using a taste sensing system, Int. J. Pharm. 438 (2012) 81–90; https://doi.org/10.1016/j.ijpharm.2012.08.047
114. M. Dilea, A. Mazare, D. Ionita and I. Demetrescu, Comparison between corrosion behaviour of implant alloys Ti6Al7Nb and Ti6Al4Zr in artificial saliva, Materials and Corrosion64 (2013) 493–499; https://doi.org/10.1002/maco.201206526
115. European Pharmacopoeia 5 with Supplements 5.1 and 5.2, Strasbourg 2005.
116. United States Pharmacopeia 29, National Formulary 24, US Pharmacopeial Convention, Rockville 2006.
117. W. Brniak, R. Jachowicz and P. Pełka, The practical approach to the evaluation of methods used to determine the disintegration time of orally disintegrating tablets (ODTs), Saudi Pharm. J. 23 (2015) 437–443; https://doi.org/10.1016/j.jsps.2015.01.015
118. B. Shen, C. Shen, X. D. Yuan, J. X. Bai, Q. Y. Lv, H. Xu, L. Dai, C. Yu, J. Han and H. L. Yua, Development and characterization of an orodispersible film containing drug nanoparticles, Eur. J. Pharm. Biopharm. 85 (2013) 1348–1356; https://doi.org/10.1016/j.ejpb.2013.09.019
119. H. Shimoda, K. Taniguchi, M. Nishimura, K. Matsuura, T. Tsukioka, H. Yamashita, N. Inagaki, K. Hirano, M. Yamamoto, Y. Kinosada and Y. Itoh, Preparation of a fast dissolving oral thin film containing dexamethasone: a possible application to antiemesis during cancer chemotherapy, Eur. J. Pharm. Biopharm. 73 (2009) 361–365; https://doi.org/10.1016/j.ejpb.2009.08.010
120. J. Shen and D. J. Burgess, In vitro dissolution testing strategies for nanoparticulate drug delivery systems: recent developments and challenges, Drug Deliv. Transl. Res. 3 (2013) 409–415; https://doi.org/10.1007/s13346-013-0129-z
121. R. C. Mashru, V. B. Sutariya, M. G. Sankalia and P. P. Parikh, Development and evaluation of fast-dissolving film of salbutamol sulphate, Drug Dev. Ind. Pharm. 31 (2005) 25–34; https://doi.org/10.1081/DDC-43947.
123. R. Kumria, V. Gupta, S. Bansal, J. Wadhwa and A. B. Nair, Oral buccoadhesive films of ondansetron: development and evaluation, Int. J. Pharm. Investig. 3 (2013) 112–118; https://doi.org/10.4103/2230-973X.114894
125. A. Adrover, A. Pedacchia, S. Petralito and R. Spera, In vitro dissolution testing of oral thin films: A comparison between USP 1, USP 2 apparatuses and a new millifluidic flow-through device, ChERD. 95 (2015) 173–178; https://doi.org/10.1016/j.cherd.2014.10.020
127. L. Perioli, V. Ambrogi, F. Angelici, M. Ricci, S. Giovagnoli, M. Capuccella and C. Rossi, Development of mucoadhesive patches for buccal administration of ibuprofen, J. Control. Release99 (2005) 73–82; https://doi.org/10.1016/j.jconrel.2004.06.005
128. M. A. Repka, K. Gutta, S. Prodduturi, M. Munjal and S. P. Stodghill, Characterization of cellulosic hot-melt extruded films containing lidocaine, Eur. J. Pharm. Biopharm. 59 (2005) 189–196; https://doi.org/10.1016/j.ejpb.2004.06.008
130. K. K. Peh and C. F. Wong, Polymeric films as vehicle for buccal delivery: swelling, mechanical, and bioadhesive properties, J. Pharm. Pharm. Sci. 2 (1999) 53–61.
131. A. Tai, R. Bianchini and R. Jachowicz, Texture analysis of cosmetic/pharmaceutical raw materials and formulation, Int. J. Cosmet. Sci. 36 (2014) 291–304; https://doi.org/10.1111/ics.12125
132. T. S. Naik, A. Khsle and H. Kanekar, Evaluation of mouth dissolving films: physical and chemical method, Int. J. Pharm. Phytopharmacol. Res. 4 (2014) 62–65.
133. H. Landová and D. Vetchý, Evaluation of the influence of formulation and process variables on mechanical properties of oral mucoadhesive films using multivariate data analysis, Biomed Res. Int. 7 (2014) 9; https://doi.org/10.1155/2014/179568
136. D. Mukherjee and S. Bharath, Design and characterization of double layered mucoadhesive system containing bisphosphonate derivative, ISRN Pharm. 19 (2013) 604–690; https://doi.org/10.1155/2013/604690
138. S. Gaisford, A. Verma, M. Saunders and P. G. Rovall, Monitoring crystallisation of drugs from fast-dissolving oral films with isothermal calorimetry, Int J. Pharm. 380 (2009) 105–111; https://doi.org/10.1016/j.ijpharm.2009.07.006
140. K. B. Liew, Y. T. Tan and K. K. Peh, Characterization of oral disintegrating film containing donepezil for Alzheimer disease, AAPS PharmSciTech13 (2012) 134–142; https://doi.org/10.1208/s12249-011-9729-4
141. F. Kianfar, B. Z. Chowdhry, M. D. Antonijevic and J. S. Boateng, Novel films for drug delivery via the buccal mucosa using model soluble and insoluble drugs, Drug Dev. Ind. Pharm. 38 (2012) 1207–1220; https://doi.org/10.3109/03639045.2011.644294
143. R. Bahri-Najafi, N. Tavakoli, M. Senemar and M. Peikanpour, Preparation and pharmaceutical evaluation of glibenclamide slow release mucoadhesive buccal film, Res. Pharm. Sci. 9 (2014) 213–223.
144. R. Patel, S. Naik, J. Patel and A. Baria, Formulation development and evaluation of mouth melting film of ondansetron, Arch. Pharm. Sci. Res. 1 (2009) 212–217.
145. K. Hermans, D. Van den Plas, S. Kerimova, R. Carleer, P. Adriaensens, W. Weyenberg and A. Ludwig, Development and characterization of mucoadhesive chitosan films for ophthalmic delivery of cyclosporine, Int. J. Pharm. 472 (2014) 10–19; https://doi.org/10.1016/j.ijpharm.2014.06.017
146. G. L. Prabhushankar, B. Gopalkrishna, K. M. Manjunatha and C. H. Girisha, Formulation and evaluation of levofloxacin dental films for periodontitis, Int. J. Pharm. Pharm. Sci. 2 (2010) 162–168.
147. R. Krampe, C. Visser, H. W. Frijlink, J. Breitkreutz, H. J. Woerdenbag and M. Preis, Oromucosal film preparations: points to consider for patient centricity and manufacturing processes, Expert Opin. Drug Deliv. 13 (2016) 493–506.
150. N. Funasaki, I. Uratsuji, T. Okuno, S. Hirota and S. Neya, Masking mechanisms of bitter taste of drugs studied with ion selective electrodes, Chem. Pharm. Bull. 54 (2006) 1155–1161.
151. A. Amelian, M. Szekalska, P. Ciosek, A. Basa and K. Winnicka, Characterization and taste masking evaluation of microparticles with cetirizine dihydrochloride and methacrylate-based copolymer obtained by spray drying, Acta Pharm. 67 (2017) 113–124; https://doi.org/10.1515/acph-2017-0002
152. F. Cilurzo, I. E. Cupone, P. Minghetti, S. Buratti, C. G. Gennari and L. Montanari, Diclofenac fast-dissolving film: suppression of bitterness by a taste-sensing system, Drug Dev. Ind. Pharm. 37 (2011) 252–259; https://doi.org/10.3109/03639045.2010.505928
155. A. Amelian, K. Wasilewska, M. Wesoły, P. Ciosek-Skibińska and K. Winnicka, Taste-masking assessment of orally disintegrating tablets and lyophilisates with cetirizine dihydrochloridemicroparticles, Saudi Pharm. J. 25 (2017) 1144–1150; https://doi.org/10.1016/j.jsps.2017.06.001